StockDuty ← Dashboard Nov 17, 2026 05:58 AM ET
SignalCorporate

Vivos Therapeutics GAAP EPS of -$0.07 beats by $0.25, revenue of $6.41M beats by $0.94M

Vivos beat EPS and revenue estimates by $0.25 and $0.94M respectively.

Vivos beat EPS and revenue estimates by $0.25 and $0.94M respectively.
Vivos beat EPS and revenue estimates by $0.25 and $0.94M respectively. — impact context not separately stored; see What changed.
Sources